Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

22 resultsUpdated October 20, 2026
1

Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain

Frontiers in Pharmacology 16 (2025)

Satoshi Kasahara; Miwako Takahashi; Takashi Suto; Taito Morita; Hideaki Obata; Shin-Ichi Niwa

2

DAT1 Gene Polymorphism in Children with Attention Deficit Hyperactivity Disorder

Iranian Journal of Pediatrics 28(3) (2018)

Seyed - Mahmoud Tabatabaei; Shahrokh Amiri; Nasrin Forghani; Seyed - Gholamreza Noorazar; Shahin Abdollahi - Fakhim; Habibeh Barzegar; Mir - Mahmoud Mirnasab

3

A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study

Iranian Journal of Pediatrics 28(1) (2018)

Katayoon Razjouyan; Arash Danesh; Mojgan Khademi; Rozita Davari-Ashtiani; Simasadat Noorbakhsh

4

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

European Child & Adolescent Psychiatry 27(10) (2018)

Sarah C. O. S. Padilha; Suzane Virtuoso; Fernanda S. Tonin; Helena H. L. Borba; Roberto Pontarolo

5

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology 30(2) (2020)

Sharon Wigal; Phillip Chappell; Donna Palumbo; Shannon Lubaczewski; Sara Ramaker; Richat Abbas

6

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children

Journal of Child and Adolescent Psychopharmacology 28(9) (2018)

Ann C. Childress; Jeffrey G. Stark

7

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder

Journal of Advanced Pharmaceutical Technology & Research 7(4) (2016)

AliHasanpour Dehkordi; Parvin Safavi; Nasim Ghasemi

8

A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

Expert Opinion on Pharmacotherapy 24(13) (2023)

Arnaud Pouchon; Rayan Nasserdine; Clément Dondé; Antoine Bertrand; Mircea Polosan; Stéphanie Bioulac

9

Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions

CNS Drugs 35(4) (2021)

Jonathan R. Young; Adare Yanagihara; Rachel Dew; Scott H. Kollins

10

Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad?

European Psychiatry 62 (2019)

Ahmed Naguy; Mohamed S Hashem; Sulaiman AlKhadhar

11

Attention Deficit Hyperactivity Disorder in Preschool-Age Children

Child and Adolescent Psychiatric Clinics of North America 26(3) (2017)

Mini Tandon; Alba Pergjika

12

Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review

Expert Opinion on Drug Safety 19(11) (2020)

Felice Iasevoli; Annarita Barone; Elisabetta Filomena Buonaguro; Licia Vellucci; Andrea de Bartolomeis

13

Symptom scores and medication treatment patterns in children with ADHD versus autism

Psychiatry Research 288 (2020)

Susan D. Mayes; James G. Waxmonsky; Raman Baweja; Richard E. Mattison; Hasan Memon; Melanie Klein; Usman Hameed; Daniel Waschbusch

14

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges

International Clinical Psychopharmacology 35(6) (2020)

Mariela Mosheva; Nina Dar; Lee Rima Madi; Abraham Weizman; Doron Gothelf

15

Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial

Psychiatry Research 251 (2017)

Leila Jahangard; Shahrokh Akbarian; Mohammad Haghighi; Mohammad Ahmadpanah; Amir Keshavarzi; Hafez Bajoghli; Dena Sadeghi Bahmani; Edith Holsboer-Trachsler; Serge Brand

16

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies

Cochrane Database of Systematic Reviews (2018)

Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Laerke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud

17

Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis

JCPP Advances 3(3) (2023)

Luisa S. Sugaya; Luis C. Farhat; Pietro Califano; Guilherme V. Polanczyk

18

The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder

Journal of Electrocardiology 50(4) (2017)

Derya Karpuz; Olgu Hallioglu; Fevziye Toros; Bahar Tasdelen

20

Psychopharmacology: Special Considerations When Working with Young Children

Pediatric School Psychology (2019)

Justin A. Barterian

22

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder

PLOS ONE 16(11) (2021)

Kensuke Nomura; Ryosuke Tarumi; Kazunari Yoshida; Mitsuhiro Sado; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida